DK0748315T3 - Anvendelse af imidazolderivater til behandling af lidelser, der involverer angiotensinreceptorer AT1 og AT2, disse produkter, fremstilling deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf - Google Patents

Anvendelse af imidazolderivater til behandling af lidelser, der involverer angiotensinreceptorer AT1 og AT2, disse produkter, fremstilling deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf

Info

Publication number: DK0748315T3
Authority: DK; Denmark
Prior art keywords: aryl; alkyl; alkenyl; drugs; products
Prior art date: 1994-03-04

Application number

DK95910603T

Other languages

English (en)

Inventor

Michel Fortin

Bertrand Heckmann

Alain Corbier

Pierre Deprez

Jacques Guillaume

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-04

Filing date

1995-02-27

Publication date

2004-03-15

1995-02-27 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DK0748315T3 publication Critical patent/DK0748315T3/da

Links

102000008873 Angiotensin II receptor Human genes 0.000 title abstract 2
108050000824 Angiotensin II receptor Proteins 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
208000035475 disorder Diseases 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
150000002460 imidazoles Chemical class 0.000 title 1
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000003118 aryl group Chemical group 0.000 abstract 7
125000000217 alkyl group Chemical group 0.000 abstract 6
125000003342 alkenyl group Chemical group 0.000 abstract 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
-1 alkylpiperazinyl Chemical group 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000005110 aryl thio group Chemical group 0.000 abstract 1
125000004104 aryloxy group Chemical group 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 abstract 1
125000002757 morpholinyl group Chemical group 0.000 abstract 1
125000004193 piperazinyl group Chemical group 0.000 abstract 1
125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
125000001422 pyrrolinyl group Chemical group 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000000638 stimulation Effects 0.000 abstract 1
125000001174 sulfone group Chemical group 0.000 abstract 1
125000004434 sulfur atom Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK95910603T 1994-03-04 1995-02-27 Anvendelse af imidazolderivater til behandling af lidelser, der involverer angiotensinreceptorer AT1 og AT2, disse produkter, fremstilling deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf DK0748315T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9402518A FR2716882B1 (fr)	1994-03-04	1994-03-04	Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
PCT/FR1995/000228 WO1995023792A1 (fr)	1994-03-04	1995-02-27	Utilisation de derives de l'imidazole au traitement d'affections impliquant les recepteurs at1 et at2 de l'angiotensine, certains de ces produits, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number	Publication Date
DK0748315T3 true DK0748315T3 (da)	2004-03-15

Family

ID=9460689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95910603T DK0748315T3 (da)	1994-03-04	1995-02-27	Anvendelse af imidazolderivater til behandling af lidelser, der involverer angiotensinreceptorer AT1 og AT2, disse produkter, fremstilling deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf

Country Status (16)

Country	Link
US (2)	US5811445A (da)
EP (2)	EP0748315B1 (da)
JP (1)	JP3881374B2 (da)
KR (1)	KR100369425B1 (da)
CN (1)	CN1146765A (da)
AT (1)	ATE257471T1 (da)
AU (1)	AU704897B2 (da)
CA (1)	CA2184111A1 (da)
DE (1)	DE69532412T2 (da)
DK (1)	DK0748315T3 (da)
ES (1)	ES2210285T3 (da)
FR (1)	FR2716882B1 (da)
HU (1)	HUT75697A (da)
PT (1)	PT748315E (da)
RU (1)	RU2141321C1 (da)
WO (1)	WO1995023792A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2716882B1 (fr) *	1994-03-04	1996-04-05	Roussel Uclaf	Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
FR2716883B1 (fr) *	1994-03-04	1996-04-26	Roussel Uclaf	Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
DE19731328A1 (de) *	1997-07-22	1999-01-28	Hoechst Ag	Imidazol-Derivate mit Biphenylsulfonylcyanamid-Seitenkette, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
EP0855392A3 (de)	1997-01-22	2000-01-05	Hoechst Aktiengesellschaft	Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832428A1 (de)	1998-07-18	2000-01-20	Hoechst Marion Roussel De Gmbh	Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832429A1 (de)	1998-07-18	2000-01-20	Hoechst Marion Roussel De Gmbh	Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6465502B1 (en)	1998-12-23	2002-10-15	Novartis Ag	Additional therapeutic use
EP1013273A1 (en) *	1998-12-23	2000-06-28	Novartis AG	Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
ATE524176T1 (de) *	1998-12-23	2011-09-15	Novartis Pharma Gmbh	Valsartan tablette
CN101011390A (zh) *	1999-01-26	2007-08-08	诺瓦提斯公司	血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
JP2002535367A (ja) *	1999-01-26	2002-10-22	ノバルティスアクチエンゲゼルシャフト	急性心筋梗塞の処置のためのアンギオテンシンｉｉレセプターアンタゴニストの使用
US6548529B1 (en)	1999-04-05	2003-04-15	Bristol-Myers Squibb Company	Heterocyclic containing biphenyl aP2 inhibitors and method
YU78601A (sh) *	1999-05-05	2005-07-19	Aventis Pharma Deutschland Gmbh.	1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže
DE10030087B4 (de) *	2000-06-19	2007-01-18	Boehringer Werkzeugmaschinen Gmbh	Verfahren und Vorrichtung zum Vermessen und Bearbeiten von Werkstücken
CA2449150C (en)	2001-05-31	2011-07-12	Vicore Pharma Ab	Tricyclic compounds useful as angiotensin ii agonists
MXPA04001253A (es) *	2001-08-09	2004-06-03	Ono Pharmaceutical Co	Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
PE20040167A1 (es) *	2002-03-28	2004-05-26	Novartis Ag	Amidas del acido sulfamico
AU2004283903B2 (en) *	2003-10-20	2010-12-02	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives as cannabinoid receptor modulators
JP2009505962A (ja) *	2005-07-29	2009-02-12	バイエル・ヘルスケア・エルエルシー	肥満を治療するためのビフェニルアミノ酸誘導体の製造および使用
EP2297113A1 (en) *	2008-04-29	2011-03-23	Theravance, Inc.	Dual-acting antihypertensive agents
EP2455388A1 (en)	2010-11-23	2012-05-23	LanthioPep B.V.	Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
RU2475243C1 (ru) *	2012-02-16	2013-02-20	Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН)	Средство, обладающее антигипертензивной активностью
WO2021023698A1 (en)	2019-08-02	2021-02-11	Lanthiopep B.V	Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer
GB2605148A (en) *	2021-03-23	2022-09-28	Vicore Pharma Ab	New compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR465368A (fr) *	1912-11-28	1914-04-15	Franz Roemer	Procédé et appareil pour le séchage de placages et autres objets ayant la forme de feuilles ou de lames
SU1598877A3 (ru) *	1986-12-31	1990-10-07	Жансен Фармасетика Н.В. (Фирма)	Способ получени производных 5-имидазолкарбоновой кислоты, или их стереоизомеров, или их солей
CA1338238C (en) *	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0409332A3 (en) *	1989-07-19	1991-08-07	Merck & Co. Inc.	Substituted triazoles as angiotensin ii antagonists
ES1011809Y (es) *	1989-10-23	1991-08-01	Minano Iglesias Jesus	Muneco-envase.
DE3937182A1 (de) *	1989-11-08	1991-05-16	Bosch Gmbh Robert	Verfahren zur bearbeitung der oberflaeche von plankommutatoren
IL98319A (en) *	1990-07-05	1997-04-15	Roussel Uclaf	Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
US5126342A (en) *	1990-10-01	1992-06-30	Merck & Co., Inc.	Imidazole angiotensin ii antagonists incorporating acidic functional groups
WO1992005784A1 (en) *	1990-10-02	1992-04-16	Warner-Lambert Company	4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
CA2058198A1 (en) *	1991-01-04	1992-07-05	Adalbert Wagner	Azole derivatives, process for their preparation, and their use
EP0505098A1 (en) *	1991-03-19	1992-09-23	Merck & Co. Inc.	Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists
TW215434B (da) *	1992-03-07	1993-11-01	Hoechst Ag
EP0577025A3 (de) *	1992-07-01	1998-02-04	Hoechst Aktiengesellschaft	Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen
EP0577023A3 (en) *	1992-07-01	1996-12-18	Hoechst Ag	Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
JP3309438B2 (ja) *	1992-09-04	2002-07-29	日本ゼオン株式会社	ブロック共重合体
FR2711367B1 (fr) *	1993-10-19	1995-12-01	Roussel Uclaf	Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus.
US5395844A (en) *	1993-06-10	1995-03-07	The Du Pont Merck Pharmaceutical Company	Imidazole 5-position substituted angiotensin II antagonists
FR2716882B1 (fr) *	1994-03-04	1996-04-05	Roussel Uclaf	Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.

1994
- 1994-03-04 FR FR9402518A patent/FR2716882B1/fr not_active Expired - Fee Related
1995
- 1995-02-27 ES ES95910603T patent/ES2210285T3/es not_active Expired - Lifetime
- 1995-02-27 PT PT95910603T patent/PT748315E/pt unknown
- 1995-02-27 CN CN95192744A patent/CN1146765A/zh active Pending
- 1995-02-27 CA CA002184111A patent/CA2184111A1/fr not_active Abandoned
- 1995-02-27 DK DK95910603T patent/DK0748315T3/da active
- 1995-02-27 HU HU9602414A patent/HUT75697A/hu unknown
- 1995-02-27 US US08/700,468 patent/US5811445A/en not_active Expired - Fee Related
- 1995-02-27 KR KR1019960704848A patent/KR100369425B1/ko not_active Expired - Fee Related
- 1995-02-27 AU AU18524/95A patent/AU704897B2/en not_active Ceased
- 1995-02-27 JP JP52272795A patent/JP3881374B2/ja not_active Expired - Fee Related
- 1995-02-27 EP EP95910603A patent/EP0748315B1/fr not_active Expired - Lifetime
- 1995-02-27 AT AT95910603T patent/ATE257471T1/de not_active IP Right Cessation
- 1995-02-27 DE DE69532412T patent/DE69532412T2/de not_active Expired - Fee Related
- 1995-02-27 RU RU96120211A patent/RU2141321C1/ru active
- 1995-02-27 WO PCT/FR1995/000228 patent/WO1995023792A1/fr not_active Ceased
- 1995-02-27 EP EP02006541A patent/EP1233015A1/fr not_active Withdrawn
1998
- 1998-06-01 US US09/088,156 patent/US5977155A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2716882A1 (fr)	1995-09-08
EP0748315A1 (fr)	1996-12-18
EP0748315B1 (fr)	2004-01-07
CN1146765A (zh)	1997-04-02
FR2716882B1 (fr)	1996-04-05
ES2210285T3 (es)	2004-07-01
ATE257471T1 (de)	2004-01-15
CA2184111A1 (fr)	1995-09-08
HUT75697A (en)	1997-05-28
DE69532412D1 (de)	2004-02-12
AU1852495A (en)	1995-09-18
DE69532412T2 (de)	2004-10-07
HU9602414D0 (en)	1996-11-28
AU704897B2 (en)	1999-05-06
EP1233015A1 (fr)	2002-08-21
JP3881374B2 (ja)	2007-02-14
RU2141321C1 (ru)	1999-11-20
US5977155A (en)	1999-11-02
US5811445A (en)	1998-09-22
PT748315E (pt)	2004-05-31
KR100369425B1 (ko)	2003-05-22
JPH09509926A (ja)	1997-10-07
WO1995023792A1 (fr)	1995-09-08
KR970701700A (ko)	1997-04-12

Publication	Publication Date	Title
DK0748315T3 (da)	2004-03-15	Anvendelse af imidazolderivater til behandling af lidelser, der involverer angiotensinreceptorer AT1 og AT2, disse produkter, fremstilling deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
AR034283A1 (es)	2004-02-18	Compuestos heterociclilindazol y azaindazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento
ATE90089T1 (de)	1993-06-15	Heterocyclische verbindungen mit therapeutischer wirkung.
BR9812239A (pt)	2000-07-18	Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto
TR200003478T2 (tr)	2001-03-21	Antikanser maddeleri olarak faydalı izotiyazol türevleri
BR0212829A (pt)	2004-08-03	Derivados de 1,8-naftiridina e seu uso para tratar diabetes e distúrbios relacionados
NO171365C (no)	1993-03-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO930505L (no)	1993-08-16	Nye azaindoler, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
BG110211A (en)	2009-02-27	SUBSTITUTED PHENIPIPERAZASES AS MODULATORS OF DOPAMIN NEUROTRANSMISSION
HUP0400384A2 (hu)	2004-09-28	Benzamidinszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE334973T1 (de)	2006-08-15	Chinazolinverbindungen
MXPA01004256A (es)	2003-06-06	N-arilamidas del acido antranilico y del acido tioantranilico.
DK249989A (da)	1989-11-25	Aryl- og heteroarylpiperazinylcarboxamider eller farmaceutisk salte deraf, deres fremstilling og anvendelse
AR035235A1 (es)	2004-05-05	Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
AR006360A1 (es)	1999-08-25	Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
BR9713884A (pt)	2000-02-29	Benzamida heterociclicamente substituìda, usos da mesma e de cetobenzamidoaldeìdos desta, e, preparação medicamentosa.
DE69321835D1 (de)	1998-12-03	7-(2-aminoethyl)-benzothiazolone
AR031526A1 (es)	2003-09-24	Nuevas fenilpiperazinas, composiciones farmaceuticas que las contienen, metodos para preparar los compuestos y las composiciones y uso de los compuestos en la preparacion de un medicamento.
NO307464B1 (no)	2000-04-10	Galantaminderivater, farmasøytisk sammensetning inneholdende samme samt deres anvendelse for fremstilling av medikamenter
DE69413118D1 (de)	1998-10-15	Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
CZ126595A3 (en)	1995-11-15	Derivatives of acylated aminoalkaneimidazoles and -triazoles, process of their preparation and pharmaceutical composition containing thereof
CY1106819T1 (el)	2012-05-23	Φαρμακα για το ξηρο δερμα
AR042617A1 (es)	2005-06-29	Disorazoles y sus derivados, utiles para el tratamiento de enfermedades tumorales benignas y malignas, y el uso de dichos compuestos para la preparacion de medicamentos.
IT1313583B1 (it)	2002-09-09	Derivati 2-amminotetralinici per la terapia del glaucoma.
ITMI920082A1 (it)	1993-07-17	Derivati solforati di acidi biliari